BANK VONTOBEL/CALL/STRYKER CORP./330/0.1/20.09.24 Share Price

Warrant

DE000VM7NVS4

Market Closed - Deutsche Boerse AG 11:32:02 28/06/2024 pm IST
2.08 EUR +0.97% Intraday chart for BANK VONTOBEL/CALL/STRYKER CORP./330/0.1/20.09.24
Current month-7.56%
1 month-2.35%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/24/28 2.08 +0.97%
27/24/27 2.06 -1.90%
26/24/26 2.1 +10.53%
25/24/25 1.9 -14.41%
24/24/24 2.22 +2.30%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 11:32 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM7NVS
ISINDE000VM7NVS4
Date issued 29/12/2023
Strike 330 $
Maturity 20/09/2024 (84 Days)
Parity 10 : 1
Emission price 1.39
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 4.51
Lowest since issue 1.23
Spread 0.03
Spread %1.40%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.2 USD
Average target price
372.9 USD
Spread / Average Target
+9.61%
Consensus